Comparative Pharmacology
Head-to-head clinical analysis: PRINCIPEN 125 versus PRINCIPEN 500.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PRINCIPEN 125 versus PRINCIPEN 500.
PRINCIPEN '125' vs PRINCIPEN '500'
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ampicillin is a penicillin beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis.
Ampicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death.
250-500 mg orally every 6 hours for mild to moderate infections; 500 mg to 1 g every 6 hours for severe infections.
500 mg orally every 6 hours for 7-14 days for mild to moderate infections; for severe infections, 500 mg orally every 4 hours.
None Documented
None Documented
Terminal elimination half-life: 0.7-1.4 hours in adults with normal renal function. Prolonged in renal impairment (up to 7-10 hours in anuria).
0.5–1 hour; prolonged in renal impairment (up to 10 hours in anuria).
Renal: approximately 60-80% of the dose excreted unchanged in urine via tubular secretion and glomerular filtration. Biliary/fecal: minimal, <10%.
Primarily renal (90% unchanged via glomerular filtration and tubular secretion); small amounts biliary/fecal (<5%).
Category C
Category C
Aminopenicillin Antibiotic
Aminopenicillin Antibiotic